NTRK2 and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, the cognitive dysfunction is exacerbated by deficient reconsolidation [33], in which case the TrkB agonist or small molecules for the induction of BDNF expression might be effective to enhance memory and cognitive function.